Superior vena cava syndrome epidemiology and demographics: Difference between revisions
Line 6: | Line 6: | ||
Superior vena cava syndrome is a common oncologic emergency. The [[incidence]] rate in the United States is approximately 15,000 individuals each year. The incidence of superior vena cava syndrome increases with age; the median age of diagnosis is between 40-60 years. Males are more commonly affected with superior vena cava syndrome than females.<ref name="pmid17168344">{{cite journal |vauthors=Higdon ML, Higdon JA |title=Treatment of oncologic emergencies |journal=Am Fam Physician |volume=74 |issue=11 |pages=1873–80 |year=2006 |pmid=17168344 |doi= |url=}}</ref> | Superior vena cava syndrome is a common oncologic emergency. The [[incidence]] rate in the United States is approximately 15,000 individuals each year. The incidence of superior vena cava syndrome increases with age; the median age of diagnosis is between 40-60 years. Males are more commonly affected with superior vena cava syndrome than females.<ref name="pmid17168344">{{cite journal |vauthors=Higdon ML, Higdon JA |title=Treatment of oncologic emergencies |journal=Am Fam Physician |volume=74 |issue=11 |pages=1873–80 |year=2006 |pmid=17168344 |doi= |url=}}</ref> | ||
==Epidemiology and | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== |
Revision as of 21:30, 19 January 2016
Superior Vena Cava Syndrome Microchapters |
Differentiating Superior Vena Cava Syndrome from Other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Superior vena cava syndrome epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Superior vena cava syndrome epidemiology and demographics |
FDA on Superior vena cava syndrome epidemiology and demographics |
CDC on Superior vena cava syndrome epidemiology and demographics |
Superior vena cava syndrome epidemiology and demographics in the news |
Blogs on Superior vena cava syndrome epidemiology and demographics |
Directions to Hospitals Treating Superior vena cava syndrome |
Risk calculators and risk factors for Superior vena cava syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Superior vena cava syndrome is a common oncologic emergency. The incidence rate in the United States is approximately 15,000 individuals each year. The incidence of superior vena cava syndrome increases with age; the median age of diagnosis is between 40-60 years. Males are more commonly affected with superior vena cava syndrome than females.[1]
Epidemiology and Demographics
Prevalence
- The prevalence of superior vena cava syndrome remains unknown.[1]
Incidence
- In the United States, the incidence of superior vena cava syndrome is 15,000 individuals each year.[1]
Gender
- Males are more commonly affected with superior vena cava syndrome than females due to the higher incidence of lung cancer among males.[2]
Race
- The prevalence of SVCS does not vary by race. However, depending on the type of cancer a racial predilection may be possible.[1]